JP2024516665A5 - - Google Patents
Info
- Publication number
- JP2024516665A5 JP2024516665A5 JP2023566594A JP2023566594A JP2024516665A5 JP 2024516665 A5 JP2024516665 A5 JP 2024516665A5 JP 2023566594 A JP2023566594 A JP 2023566594A JP 2023566594 A JP2023566594 A JP 2023566594A JP 2024516665 A5 JP2024516665 A5 JP 2024516665A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarker
- subject
- amount
- strem1
- sflt1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21171495 | 2021-04-30 | ||
| EP21171495.1 | 2021-04-30 | ||
| PCT/EP2022/061587 WO2022229442A2 (en) | 2021-04-30 | 2022-04-29 | Presepsin marker panels for early detection of sepsis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516665A JP2024516665A (ja) | 2024-04-16 |
| JP2024516665A5 true JP2024516665A5 (https=) | 2025-05-09 |
Family
ID=75746437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566594A Pending JP2024516665A (ja) | 2021-04-30 | 2022-04-29 | 敗血症の早期検出のためのプレセプシンマーカーパネル |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240230672A1 (https=) |
| EP (1) | EP4330682A2 (https=) |
| JP (1) | JP2024516665A (https=) |
| CN (1) | CN117321419A (https=) |
| WO (1) | WO2022229442A2 (https=) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999006445A1 (en) | 1997-07-31 | 1999-02-11 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-15 |
| JP2002543841A (ja) | 1999-05-17 | 2002-12-24 | バイオファーム ゲゼルシャフト ツア バイオテクノロジシェン エントヴィックルング ウント ツム フェルトリーブ フォン ファルマカ エムベーハー | ＴＧＦ−βスーパーファミリーの新規のメンバーであるＧＤＦ―１５の神経保護特性 |
| CA2476597C (en) | 2002-02-28 | 2011-05-17 | Metanomics Gmbh & Co. Kgaa | Mass spectrometry method for analysing mixtures of substances |
| WO2005113585A2 (en) | 2004-05-20 | 2005-12-01 | Acceleron Pharma Inc. | Modified tgf-beta superfamily polypeptides |
| US20090197794A1 (en) * | 2005-07-13 | 2009-08-06 | Aird William C | Methods of Diagnosing and Treating an Inflammatory Response |
| CN103123359B (zh) | 2007-08-03 | 2015-07-29 | B.R.A.H.M.S有限公司 | 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用 |
| EP2388594A1 (en) * | 2010-05-17 | 2011-11-23 | Roche Diagnostics GmbH | GDF-15 based means and methods for survival and recovery prediction in acute inflammation |
| JP2012159356A (ja) * | 2011-01-31 | 2012-08-23 | Mochida Pharmaceut Co Ltd | 敗血症診断用組合せマーカー |
| ES2734494T3 (es) * | 2011-12-08 | 2019-12-10 | Astute Medical Inc | Métodos y usos para el diagnóstico de una lesión renal y de una insuficiencia renal |
| RU2016112915A (ru) | 2013-09-05 | 2017-10-09 | Эф-Ай-Оу Корпорейшн | Биомаркеры для раннего выявления критической или угрожающей жизни ответной реакции на заболевание и/или ответной реакции на лечение |
| GB201402293D0 (en) * | 2014-02-11 | 2014-03-26 | Secr Defence | Biomarker signatures for the prediction of onset of sepsis |
| JP6859334B2 (ja) * | 2015-10-08 | 2021-04-14 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 手術前に測定した際にａｋｉのリスクを予測するためのｉｇｆｂｐ７ |
| EP3631460B1 (en) * | 2017-05-31 | 2023-11-15 | B.R.A.H.M.S GmbH | Mmp-8 as a marker for identifying infectious disease |
| EP3502706A1 (en) * | 2017-12-20 | 2019-06-26 | B.R.A.H.M.S GmbH | Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin |
-
2022
- 2022-04-29 CN CN202280031683.XA patent/CN117321419A/zh active Pending
- 2022-04-29 JP JP2023566594A patent/JP2024516665A/ja active Pending
- 2022-04-29 WO PCT/EP2022/061587 patent/WO2022229442A2/en not_active Ceased
- 2022-04-29 US US18/557,890 patent/US20240230672A1/en active Pending
- 2022-04-29 EP EP22724117.1A patent/EP4330682A2/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2617520T3 (es) | Diagnóstico y control de enfermedad renal crónica utilizando NGAL | |
| Lee et al. | Biomarkers for Recurrent Wheezing and Asthma in Preschool Children. | |
| Peng et al. | Correlation of Krebs von den Lungen-6 and fibronectin with pulmonary fibrosis in coronavirus disease 2019 | |
| CN111279195A (zh) | 原发性肝癌的预后和随访方法 | |
| JP5759372B2 (ja) | 糖尿病性腎症の検査方法 | |
| Wan et al. | Combining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure | |
| Ondruschka et al. | Post-mortem in situ stability of serum markers of cerebral damage and acute phase response | |
| CN105705652B (zh) | 协助鉴别诊断中风的方法 | |
| Bering et al. | Bioelectrical Impedance Analysis–Derived Measurements in Chronic Hepatitis C: Clinical Relevance of Fat‐Free Mass and Phase Angle Evaluation | |
| AU2012343537B2 (en) | Biomarker-based methods and biochips for aiding the diagnosis of stroke | |
| US20130210667A1 (en) | Biomarkers for Predicting Kidney and Glomerular Pathologies | |
| Peel et al. | Biomarkers in adult asthma: a systematic review of 8-isoprostane in exhaled breath condensate | |
| Romano et al. | Diagnostic reliability of the procalcitonin serum marker in septic frail patient | |
| Hou et al. | The value of small airway function parameters and fractional exhaled nitric oxide for predicting positive methacholine challenge test in asthmatics of different ages with FEV1≥ 80% predicted | |
| JP2024516680A5 (https=) | ||
| JP2024516678A5 (https=) | ||
| JP2024516665A5 (https=) | ||
| JP2024516677A5 (https=) | ||
| RU2020127365A (ru) | Способы, применения и комплекты для диагностики пародонтита | |
| Yang et al. | Presepsin as a predictor of septic shock and mortality in patients with urinary tract infection according to the Sepsis-3 definitions. | |
| JP2024516001A5 (https=) | ||
| JP2024516681A5 (https=) | ||
| JP2024537774A5 (https=) | ||
| JP7029139B2 (ja) | 非アルコール性脂肪性肝炎の検出を補助する方法 | |
| JP2024515086A5 (https=) |